Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?
Article in Journal of Clinical Medicine (September 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Personality Traits and Psychiatric Comorbidities of Patients with Chronic Plaque Psoriasis
Book chapter (August 2024)
The Prevalence of Depression and Acceptance Rate of Referral to Psychiatrist Among Psoriatic Patients in Saudi Arabia
Article in Cureus (June 2024)